View in EDS PDF Full Text

Tetanus-diphtheria vaccine can prime SARS-CoV-2 cross-reactive T cells.

Saved in:
Bibliographic Details
Title: Tetanus-diphtheria vaccine can prime SARS-CoV-2 cross-reactive T cells.
Authors: Fernandez SA; Department of Immunology & O2, Faculty of Medicine, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain., Pelaez-Prestel HF; Department of Immunology & O2, Faculty of Medicine, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain., Fiyouzi T; Department of Immunology & O2, Faculty of Medicine, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain., Gomez-Perosanz M; Department of Immunology & O2, Faculty of Medicine, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain., Reiné J; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.; Oxford Vaccine Group, University of Oxford, Oxford, United Kingdom., Reche PA; Department of Immunology & O2, Faculty of Medicine, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain.
Source: Frontiers in immunology [Front Immunol] 2024 Jul 18; Vol. 15, pp. 1425374. Date of Electronic Publication: 2024 Jul 18 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39091504
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Tetanus-diphtheria vaccine can prime SARS-CoV-2 cross-reactive T cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fernandez+SA%22">Fernandez SA</searchLink>; Department of Immunology & O2, Faculty of Medicine, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Pelaez-Prestel+HF%22">Pelaez-Prestel HF</searchLink>; Department of Immunology & O2, Faculty of Medicine, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Fiyouzi+T%22">Fiyouzi T</searchLink>; Department of Immunology & O2, Faculty of Medicine, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gomez-Perosanz+M%22">Gomez-Perosanz M</searchLink>; Department of Immunology & O2, Faculty of Medicine, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Reiné+J%22">Reiné J</searchLink>; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.; Oxford Vaccine Group, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Reche+PA%22">Reche PA</searchLink>; Department of Immunology & O2, Faculty of Medicine, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Jul 18; Vol. 15, pp. 1425374. <i>Date of Electronic Publication: </i>2024 Jul 18 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39091504
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2024.1425374
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1425374
    Titles:
      – TitleFull: Tetanus-diphtheria vaccine can prime SARS-CoV-2 cross-reactive T cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fernandez SA
      – PersonEntity:
          Name:
            NameFull: Pelaez-Prestel HF
      – PersonEntity:
          Name:
            NameFull: Fiyouzi T
      – PersonEntity:
          Name:
            NameFull: Gomez-Perosanz M
      – PersonEntity:
          Name:
            NameFull: Reiné J
      – PersonEntity:
          Name:
            NameFull: Reche PA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 07
              Text: 2024 Jul 18
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1